Historical record - last NADAC effective date: 2/21/2018
Product Information
ZYCLARA 3.75% CREAM PUMP is a brand product labeled by Bausch Health US LLC, priced at $158.1732 per GM under NDC 99207027175. Its NADAC has been published 273 times since Nov 28, 2013.
FDA first approved this application on Mar 25, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/g
Manufacturer
Bausch Health US LLCNDC
99207027175
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Effective Date
2/21/2018
Active Ingredients
IMIQUIMODApproval Type
New Drug (NDA)
FDA Application
NDA022483FDA Approved
3/25/2010
TE Code
AB
On Market Since
1/1/2012
Pharmacological Classes
Price Statistics
The NADAC for ZYCLARA 3.75% CREAM PUMP has been published 273 times since Nov 28, 2013, and over the history we have for it it has risen 53.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $158.1732 per GM |
|---|---|
| All-time high | $159.0134 (Feb 14, 2018) |
| All-time low | $100.5593 (Dec 18, 2013) |
| Median price | $135.1528 |
| Average price | $136.7047 |
| Largest weekly change | +15.0% (Jan 15, 2014) |
| Weeks tracked | 273 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+53.9%
Last surveyed Feb 13, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 85% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
imiquimod market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZYCLARA 3.75% CREAM PUMP?
The current National Average Drug Acquisition Cost (NADAC) for ZYCLARA 3.75% CREAM PUMP, manufactured by Bausch Health US LLC, is $158.1732 per GM (NDC 99207027175), effective Feb 13, 2019.
How has the price of ZYCLARA 3.75% CREAM PUMP changed over time?
Over the history we have for it, the NADAC for ZYCLARA 3.75% CREAM PUMP has risen 53.9%. It has been tracked across 273 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZYCLARA 3.75% CREAM PUMP?
Since Nov 28, 2013, the NADAC for ZYCLARA 3.75% CREAM PUMP has ranged from a low of $100.5593 (Dec 18, 2013) to a high of $159.0134 (Feb 14, 2018), with a median of $135.1528 per GM.
Are there cheaper alternatives to ZYCLARA 3.75% CREAM PUMP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IMIQUIMOD 3.75% CREAM PUMP, is $24.3913 per GM — about 85% below ZYCLARA 3.75% CREAM PUMP.
Who manufactures ZYCLARA 3.75% CREAM PUMP?
ZYCLARA 3.75% CREAM PUMP (NDC 99207027175) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.